sarcosine has been researched along with Adenoma, Prostatic in 3 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma sarcosine was measured using gas chromatography-mass spectrometry (GC-MS) in adults classified as noncancerous controls (with benign prostate hyperplasia [BPH], n = 36), with prostatic intraepithelial neoplasia (PIN, n = 16), or with PCa (n = 27)." | 7.96 | Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia. ( Appolonova, SA; Brito, A; Enikeev, DV; Fodor, M; Lartsova, EV; Lerner, YV; Lyundup, AV; Markin, PA; Mikhajlov, VY; Moskaleva, N; Potoldykova, NV; Shpot, YV, 2020) |
| "Plasma sarcosine was measured using gas chromatography-mass spectrometry (GC-MS) in adults classified as noncancerous controls (with benign prostate hyperplasia [BPH], n = 36), with prostatic intraepithelial neoplasia (PIN, n = 16), or with PCa (n = 27)." | 3.96 | Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia. ( Appolonova, SA; Brito, A; Enikeev, DV; Fodor, M; Lartsova, EV; Lerner, YV; Lyundup, AV; Markin, PA; Mikhajlov, VY; Moskaleva, N; Potoldykova, NV; Shpot, YV, 2020) |
| "Post-treatment sarcosine levels were elevated in 266 (52%) patients and highly elevated (≥200 nmol/L) in 71 (13%) patients." | 1.48 | Post-treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer. ( Adam, V; Cernei, N; Gumulec, J; Heger, Z; Lackova, Z; Pacik, D; Plevova, M; Raudenska, M; Sorokac-Kubolkova, A; Strmiska, V; Zitka, O, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Markin, PA | 1 |
| Brito, A | 1 |
| Moskaleva, N | 1 |
| Fodor, M | 1 |
| Lartsova, EV | 1 |
| Shpot, YV | 1 |
| Lerner, YV | 1 |
| Mikhajlov, VY | 1 |
| Potoldykova, NV | 1 |
| Enikeev, DV | 1 |
| Lyundup, AV | 1 |
| Appolonova, SA | 1 |
| Gumulec, J | 1 |
| Raudenska, M | 1 |
| Pacik, D | 1 |
| Plevova, M | 1 |
| Sorokac-Kubolkova, A | 1 |
| Lackova, Z | 1 |
| Cernei, N | 1 |
| Strmiska, V | 1 |
| Zitka, O | 1 |
| Heger, Z | 1 |
| Adam, V | 1 |
| Kumar, D | 1 |
| Gupta, A | 1 |
| Mandhani, A | 1 |
| Sankhwar, SN | 1 |
3 other studies available for sarcosine and Adenoma, Prostatic
| Article | Year |
|---|---|
Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia.
Topics: Aged; Aged, 80 and over; Biomarkers; Biomarkers, Tumor; Biopsy; Gas Chromatography-Mass Spectrometry | 2020 |
Post-treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers; Humans; Male; Neoplasm Recurrence, Local; Posto | 2018 |
NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
Topics: Aged; Biomarkers, Tumor; Biopsy; Citric Acid; Diagnosis, Differential; Digital Rectal Examination; G | 2016 |